August 01, 1996; 47 (2) ARTICLES
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide
A double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation
D. M. Karussis, Z. Meiner, D. Lehmann, J.-M. Gomori, A. Schwarz, A. Linde, O. Abramsky
First published August 1, 1996, DOI: https://doi.org/10.1212/WNL.47.2.341
D. M. Karussis
Z. Meiner
D. Lehmann
J.-M. Gomori
A. Schwarz
A. Linde
Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide
A double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation
D. M. Karussis, Z. Meiner, D. Lehmann, J.-M. Gomori, A. Schwarz, A. Linde, O. Abramsky
Neurology Aug 1996, 47 (2) 341-346; DOI: 10.1212/WNL.47.2.341
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 47 no. 2 341-346
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published August 1, 1996.
Copyright & Usage:
Copyright 1996 by Advanstar Communications Inc.
Author Disclosures
- D. M. Karussis, MD, PhD,
- Z. Meiner, MD,
- D. Lehmann, PhD,
- J.-M. Gomori, MD,
- A. Schwarz, MD,
- A. Linde, MB and
- O. Abramsky, MD, PhD
- D. M. Karussis, MD, PhD,
- Z. Meiner, MD,
- D. Lehmann, PhD,
- J.-M. Gomori, MD,
- A. Schwarz, MD,
- A. Linde, MB and
- O. Abramsky, MD, PhD
- From the Departments of Neurology (Drs. Karussis, Meiner, Lehmann, and Abramsky) and Radiology (Drs. Gomori and Schwarz), Hadassah University Hospital and Hebrew University Hadassah Medical School, Ein-Karem, Jerusalem, Israel; and the Department of Clinical Research (Dr. Linde), Pharmacia, Lund, Sweden.
- Preliminary results from this trial were presented at the 47th annual meeting of the American Academy of Neurology in Seattle, Washington, May 1995.
- This study was supported by Pharmacia, Sweden, and partially by the Nina Silverman memorial neurological endowing fund, the Zeev Aram grant for multiple sclerosis, and the Hilda Katz Blaustein grant for neurological research.
- Received September 5, 1995. Accepted in final form January 18, 1996.
- Address correspondence and reprint requests to Dr. Oded Abramsky, Department of Neurology, Hadassah University Hospital, Ein Karem, Jerusalem, Israel, IL-91120.
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.